Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019332
Filing Date
2024-05-15
Accepted
2024-05-14 17:44:53
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1413034
2 ex31-1.htm EX-31.1 20266
3 ex31-2.htm EX-31.2 20255
4 ex32-1.htm EX-32.1 6519
5 ex32-2.htm EX-32.2 6716
  Complete submission text file 0001493152-24-019332.txt   7892756

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20240331.xsd EX-101.SCH 64591
7 XBRL CALCULATION FILE otlc-20240331_cal.xml EX-101.CAL 46951
8 XBRL DEFINITION FILE otlc-20240331_def.xml EX-101.DEF 315471
9 XBRL LABEL FILE otlc-20240331_lab.xml EX-101.LAB 436622
10 XBRL PRESENTATION FILE otlc-20240331_pre.xml EX-101.PRE 390822
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1286174
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 24946115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)